The generic name of Ligunza is Erythromycin Succinate, which belongs to the class of macrolide antibacterial drugs, can be used to treat tonsillitis caused by hemolytic streptococcus, Streptococcus pneumoniae and other bacterial infections, as well as mycoplasma and chlamydia infections, but can not be used to treat viral infections caused by tonsillitis, and the severity of the disease, the response to the drug to determine that it can not be generalized.
Tonsillitis is caused by bacteria or viruses and other pathogenic microbial infections, clinical common pathogenic bacteria such as streptococcus, staphylococcus, etc., pathogenic viruses are commonly adenovirus, rhinovirus, etc..
Erythromycin can be used to treat tonsillitis caused by streptococcus, staphylococcus and other bacterial infections, which can shorten the course of tonsillitis and relieve symptoms such as sore throat caused by tonsillitis. However, tonsillitis caused by viral infection cannot be treated with this medicine.
Erythromycin ethylsuccinate main adverse reactions include diarrhea, abdominal pain, nausea, vomiting and other gastrointestinal reactions, large doses can lead to patients with hearing loss, and some patients may also experience allergic reactions such as rash, itching, and can occasionally lead to cardiac arrhythmia, oral or vaginal candida infection. Severe hepatic impairment, allergic to the product and pregnant women are prohibited.
During the period of taking need to pay attention to the existence of serious renal impairment should be appropriate to reduce the amount of drugs, regular check of liver function during the use of drugs.
It is recommended that patients go to the hospital to improve the examination, to clarify the cause of the disease, the drug needs to be used under the guidance of a professional physician.
Support Us
Discussion
Share your experience, or seek help from fellow patients.
